Interv Akut Kardiol 2011; 10(Suppl. A): 6-13

Severe pulmonary embolism

Jan Bělohlávek, Vladimír Dytrych, Aleš Král, Ondřej Šmíd, Aleš Linhart
II. interní klinika kardiologie a angiologie,
Komplexní kardiovaskulární centrum VFN a 1. LF UK, Praha

Pulmonary embolism is a relatively common condition with considerable mortality, however, well manageable when diagnosed early.

Early adequate treatment is usually effective, when initiated without delay. The severity of pulmonary embolism is primarily determined

by its haemodynamic impact on right ventricular function and preservation of adequate forward cardiac output and organ functions.

However, the severity of this condition may also be affected by the potential development of other complications, such as recurrence of

embolism, embolization of free-floating thrombi to the pulmonary or systemic vascular beds, development of respiratory insufficiency

and the occurrence of treatment-related complications, particularly bleeding.

Keywords: pulmonary embolism, thrombolysis, risk stratification, haemodynamics

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bělohlávek J, Dytrych V, Král A, Šmíd O, Linhart A. Severe pulmonary embolism. Interv Akut Kardiol. 2011;10(Suppl. A):6-13.
Download citation

References

  1. Davidson B, Karmy-Jones R. When pulmonary embolism treatment isn't working. Chest 2006; 129: 839-840. Go to original source... Go to PubMed...
  2. Widimský P, Hlinomaz O, Kala P, Jirmář R. Diagnostika a léčba akutního infarktu myokardu s elevacemi ST. Doporučení České kardiologické společnosti 2009. Cor Vasa 2009; 51: 724-740. Go to original source...
  3. Widimský J, Malý J, Eliáš P, et al. Doporučení pro diagnostiku a léčbu akutní plicní embolie. Vnitř. Lék 2008; 54: 1S25-1S72.
  4. Torbicki A, Perrier A, Konstantidines S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008; 29: 2276-2315. Go to original source... Go to PubMed...
  5. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389. Go to original source... Go to PubMed...
  6. Ibrahim SA, Stone RA, Obrosky DS, et al. Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Arch Intern Med. 2008; 168(20): 2183-2190. Go to original source... Go to PubMed...
  7. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000; 101(24): 2817-2822. Go to original source... Go to PubMed...
  8. Král A, Bělohlávek J, Dytrych V, et al. Současná léčba pacientů s akutní a subakutní plicní embolií s ohledem na nově publikovaná doporučení diagnostiky a léčby tohoto onemocnění. Cor Vasa 2009; 51(11-12). Go to original source... Go to PubMed...
  9. Widimský J. Několik poznámek k plicní embolii. Cor Vasa 2009; 51(11-12). Go to original source... Go to PubMed...
  10. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pumonary embolism. N Engl J Med 2002; 347: 1143. Go to original source... Go to PubMed...
  11. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-1268. Go to original source... Go to PubMed...
  12. Kucher N, Printzen G, Goldhaber S. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-2547. Go to original source... Go to PubMed...
  13. Jiménez D, Uresandi F, Otero R, et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism. Chest 2009; 136: 974-982. Go to original source... Go to PubMed...
  14. Ferrari E, Benhamou M, Berthier F, Baudouy M. Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic treatment. Chest. 2005; 127(3): 1051-1053. Go to original source... Go to PubMed...
  15. Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol. 2007; 50(18): 1742-1751. Go to original source... Go to PubMed...
  16. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004; 110(6): 744-749. Go to original source... Go to PubMed...
  17. Dalen JE, Alpert JS, Hirsh J. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med. 1997; 157(22): 2550-2556. Go to original source...
  18. Levine MN. Thrombolytic therapy for venous thromboembolism. Complications and contraindications. Clin Chest Med. 1995; 16(2): 321-328. Go to original source... Go to PubMed...
  19. Meneveau N, Séronde MF, Blonde MC, et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest. 2006; 129(4): 1043-1050. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.